Rajavelu Esther

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Rajavelu Esther's trades of Spero Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-06 2026-05-04 S Sale
74,789 -2.2%
495.73
US$900,718
74,789 -2.2% 495.73 US$900,718
2026-02-09 2026-02-06 S Sale
98,478 +11.7%
231.70
US$2,291,416
98,478 +11.7% 231.70 US$2,291,416
2026-02-09 2026-02-06 S Sale
87,845 +1.5%
49.46
US$1,532,052
87,845 +1.5% 49.46 US$1,532,052
2026-02-04 2026-02-02 S Sale
18,442 -1.6%
2.20
US$40,572
18,442 -1.6% 2.20 US$40,572
2026-02-04 2026-02-02 S Sale
18,442 -1.6%
2.20
US$40,572
18,442 -1.6% 2.20 US$40,572
2025-11-12 2025-11-07 S Sale
40,270 -4.4%
2.37
US$95,440
40,270 -4.4% 2.37 US$95,440
2025-02-05 2025-02-05 S Sale
20,689 -2.8%
0.78
US$16,137
20,689 -2.8% 0.78 US$16,137
2024-11-12 2024-11-08 S Sale
17,245 -4.3%
1.30
US$22,418
17,245 -4.3% 1.30 US$22,418
2024-11-12 2024-11-07 S Sale
23,351 -5.6%
1.31
US$30,590
23,351 -5.6% 1.31 US$30,590